3 results about "Diagnostic scan" patented technology

We provide a compact, portable AI-based diagnostic scan and analysis device that improves healthcare delivery in diverse clinical and emergency settings. [Solution] The portable AI-based diagnostic scan analysis device 100 includes a system initialization interface 101 and a power control and startup hardware module 102 for establishing operational readiness and controlled power distribution. The diagnostic scan interface hardware module 103 acquires image, biosignal, or optical scan data, and the user input and parameter selection hardware module 104 enables the setting of diagnostic parameters. System safety is ensured by the error detection and safety monitoring hardware module 105, after which the scan is initiated by the scan execution trigger hardware module 106. Diagnostic information is presented by the data display and status interface hardware module 107, and processed by the active diagnostic processing hardware module 108 by executing an artificial intelligence algorithm.

This specification provides a multi-contrast agent combined scanning control system and method, relating to the field of medical device technology. The method includes: after delivering a current contrast agent from a syringe based on a current delivery command, monitoring the contrast agent concentration at a preset monitoring layer to obtain the current CT value; if the current CT value meets a preset trigger condition, generating a next delivery command and sending the next delivery command to the syringe; using the next delivery command as a new current delivery command, and using the next contrast agent to be delivered as a new current contrast agent, repeating the above steps; if the CT value of the target site corresponding to the last delivered contrast agent meets the trigger condition, generating a scanning command to initiate a diagnostic scan, thereby controlling the CT scanner to perform a diagnostic scan and acquire scanning data from multiple target sites. In this way, the amount of diagnostic image information can be increased while reducing the amount of contrast agent used and minimizing radiation.

Processes and materials to detect cancer, transplant rejection, or fetal genetic abnormalities from a biopsy are described. In some cases, cell-free nucleic acids can be sequenced, and the sequencing result can be utilized to detect sequences indicative of a neoplasm, transplant rejection, or fetal genetic abnormality. Detection of somatic variants occurring in phase and / or insertions and deletions (indels) can indicate the presence of cancer, transplant rejection, or fetal genetic abnormalities in a diagnostic scan, and a clinical intervention can be performed.